The effects of direct and indirect activation of adenylyl cyclase on the production of intracellular and extracellular cAMP and cGMP by 13-to 16-day-old cattle embryos were determined. Embryos were incubated for 2 h in a Krebs Ringer bicarbonate medium containing the phosphodiesterase inhibitor isobutyl-methylxanthine, to which stimulating agents forskolin (100 \g=m\moll \ m=-\ 1), cholera toxin (2 \g=m\gml \ m=-\ 1), or both were added. Total (intraand extracellular) basal cAMP and cGMP concentrations ranged from 6.65 \m=+-\0.895 to 3.4 \ m=+-\ 0.708 fmol \ g=m\ g\ m=-\ 1protein in 13-day-old embryos and from 4.05 \ m=+-\ 1.151 to 0.19 \ m=+-\ 0.041 fmol \ g=m\ g\ m=-\ 1protein in 16-day-old embryos. Forskolin induced an increase (P < 0.001) in cAMP that ranged from 5.4-fold on day 13 to 2.7-fold on day 16, whereas cholera toxin induced an increase (P < 0.001) that ranged from 30-fold at day 13 to 21-fold at day 16, similar to the effect of forskolin and cholera toxin combined. Individually, forskolin and cholera toxin had no effect on cGMP concentrations, but together they induced an increase (P < 0.05). cAMP (P < 0.01) and cGMP (P < 0.001) concentrations decreased with embryo age from day 13 to day 16 for all treatments; the decrease was greater for cGMP than cAMP (5-24-fold versus 1.6-3.3-fold, respectively). It is concluded that inducible adenylyl cyclase is present in 13-to 16-day-old cattle embryos and that the embryos secrete cAMP and cGMP into the incubation medium. In addition, basal and inducible concentrations of cAMP and cGMP decrease with embryo age from day 13 to day 16. These observations indicate that cAMP and cGMP may have a role in the rapid embryonic cell proliferation that occurs at this time or in signalling to the endometrium.
Introduction cAMP and cGMP are present in, and secreted by, 14-to 16-day-old cattle blastocysts during in vitro culture (Grealy et ah, 1997) . In adult cells, cAMP and cGMP are involved in cell cycle control, differentiation and cell proliferation (Boynton and Whitfield, 1983; Dumont et ah, 1989; Christensen et ah, 1996 ; Garcia-Ocana et ah, 1996; Sarkar et ah, 1997) , and they may have similar roles in cell proliferation and differentiation during preimplantation embryo development.
Many hormones, neurotransmitters and other 'first messengers' act by controlling cAMP concentrations. This control is achieved by altering the activity of adenylyl cyclase, the enzyme that synthesizes cAMP. Binding of the first messenger to an appropriate receptor causes activation of the G protein Gs, which in turn stimulates adenylyl cyclase (Sunahara et ah, 1996) , thereby increasing cellular cAMP concentrations. Adenylyl cyclase may be activated directly by forskolin, which reversibly binds to the catalytic subunit (Seamon and Daly, 1981) , whereas the G protein may be activated directly by cholera toxin, which catalyses the ADP ribosylation of the a subunit of the Gs regulatory protein (Fishman, 1990) . cAMP exerts its effects in the cell by binding to, and activating, its specific protein kinase, cAMPdependent protein kinase (PKA), which in turn, activates or inhibits other proteins in the cell by phosphorylation.
cGMP is formed after activation of guanylyl cyclases and activates or inhibits several target proteins in the cell. The effects include activation of cGMP-dependent protein kinase (PKG), regulation of ion channels, and activation or inhibition of cAMP phosphodiesterases (PDE) which break down cAMP in the cell (Goy, 1991) . In this way, cGMP interacts with the cAMP pathway.
Both cAMP and cGMP are exported from mammalian cells (for reviews see Barber and Butcher, 1983; Hamet and Tremblay, 1991 (Amlal et ah, 1996) . Cattle blastocysts secrete cAMP and cGMP during culture in vitro (Grealy et ah, 1997) , but the function of these secreted cyclic nucleotides in cattle embryos has not been established.
The adenylyl cyclase present in bovine and mouse oocytes may be atypical because it is insensitive to cholera toxin but responds to forskolin stimulation (Manejwala et ah, 1986; Bilodeau et ah, 1993) . This is in contrast to the adenylyl cyclases of adult cells, which respond both to cholera toxin and forskolin (Sunahara et ah, 1996) . In mouse embryos, sensitivity to cholera toxin increases from the eight-cell to the blastocyst stage (Manejwala et ah, 1986) For determination of dose-response relationships, the PDE inhibitor IBMX (0.1-10 mmol H), the direct activator of adenylyl cyclase forskolin (1-100 pmol I""1) and the indirect activator of adenylyl cyclase cholera toxin (0.2-20 pg ml l"1) were used. Doses of IBMX, forskolin and cholera toxin were within the range used in studies on cattle oocytes (Bilodeau et ah, 1993) and mouse embryos (Manejwala et ah, 1986) . On the basis of the results from the dose-response study, 13-to 16-day-old cattle embryos were treated with 100 pmol forskolin l~\ 2 pg cholera toxin ml-1, or a combination of 100 pmol forskolin 1_1 and 2 pg cholera toxin ml"1. IBMX was dissolved in 1 mol NaOH H and neutralized with 0.1 mol HC11"1 to give a 50 mmol H stock. This was dissolved in KRB to give the final concentration. Forskolin was dissolved in dimethyl sulfoxide (DMSO) to give a 50 mmol l"1 stock and cholera toxin was dissolved in distilled H20 to give a 1 mg ml-1 stock. Cholera toxin (µ ml"1) (Fig. la,b) .
Dose-response relationshipsforforskolin
Forskolin elicited a dose-dependent increase in total cAMP (P < 0.001), but had no significant effect on cGMP concentrations. Intracellular cAMP concentrations were highest at 100 pmol forskolin I"1, while the increase in extracellular cAMP was smaller and was maximal at 10 pmol l"1 and there was no further increase at 100 pmol l"1 (Fig. lc,d ).
Dose-response relationshipsfor cholera toxin
Cholera toxin elicited a large increase in total cAMP concentrations (P < 0.001) at all concentrations examined.
The intracellular cAMP response was maximal at 0.2 pg ml"1 and there was a smaller response at the highest concentration (20 pg ml1). Extracellular concentrations of cAMP were highest at 2 pg cholera toxin ml"1 and also decreased at the highest concentration. Cholera toxin did not affect intracellular cGMP concentrations, but extracellular concen¬ trations increased at 20 pg ml"1 (P < 0.05; Fig. le,f) . On the basis of these results, IBMX (1 mmol l1) was included in all subsequent treatments, and forskolin and cholera toxin were used at 100 pmol l"1 and 2 pg ml1, respectively, to avoid the non-specific effects observed at the higher concentrations.
Overall treatment effects in 13-to 16-day-old embryos Effect offorskolin on 13-to 16-day-old embryos Forskolin (100 pmol l"1) elicited a significant increase in intra-and extracellular cAMP concentrations compared with IBMX controls on days 13, 14, 15 and 16 (P < 0.001; Fig. 2 ).
There was also a decrease in intra-and extracellular cAMP concentrations with day (P < 0.001) and a day treatment interaction (P < 0.001); the increase in cAMP concentrations elicited by forskolin was lower at days 15 and 16 than at days 13 and 14. Intra-and extracellular cGMP concentrations decreased with day (P < 0.001), but there was no effect of forskolin treatment on cGMP concentrations.
In the IBMX controls, there was no significant change in extracellular cAMP with day, but intracellular cAMP and cGMP (P < 0.01) and extracellular cGMP (P < 0.001) decreased with day.
Effect of cholera toxin on 13-to 16-day-old embryos Cholera toxin (2 pg ml-1) elicited a significant increase (P < 0.001) in intra-and extracellular cAMP concentrations (Fig. 2) . Intra-and extracellular cAMP concentrations decreased with day (P < 0.01) and there was a day treatment interaction (P < 0.01). Intra-and extracellular cGMP concentrations decreased with day (P < 0.01) but there was no effect of cholera toxin on cGMP concentrations.
Cholera toxin (2 pg ml"1) elicited higher intra-and extracellular cAMP concentrations than forskolin (P < 0.001).
Effect of combined treatment with forskolin and cholera toxin in 13-to 16-day-old embryos Combined treatment with forskolin (100 pmol l"1) and cholera toxin (2 pg ml"1) elicited a significant increase in intra-and extracellular cAMP concentrations compared with IBMX controls on days 13, 14, 15 and 16 (P < 0.001; Fig. 2 ).
Intracellular cAMP concentrations also decreased with day ( < 0.05) from day 13 to day 16 and there was a day treatment interaction (P < 0.05). Intra-and extracellular cGMP concentrations decreased with day (P < 0.001). Intra¬ cellular cGMP concentrations were increased (P < 0.005), whereas extracellular cGMP concentrations were unaffected by combined treatment with forskolin and cholera toxin. Forskolin and cholera toxin in combination elicited higher concentrations of intra-and extracellular cAMP (P < 0.001) and cGMP (P < 0.05) than forskolin alone. There was no significant difference between total intra-and extracellular cAMP concentrations elicited by forskolin and cholera toxin together and cholera toxin alone. However, forskolin and cholera toxin in combination elicited higher concentrations of intracellular cGMP than cholera toxin alone.
The overall effect of the treatments was demonstrated by examining total cAMP or cGMP concentrations (Fig. 2e,f) .
Total cAMP concentrations in the IBMX controls showed a small decrease from day 13 to day 16 (1.6-fold; < 0.05).
Total cAMP concentrations were increased by forskolin (P < 0.001) and decreased steadily with day from day 13 to day 16 (3.3-fold; < 0.001). The increase in totalcAMP concentrations elicited by cholera toxin (P < 0.001) was much larger than that elicited by forskolin, and also decreased between day 13 and day 16 (2.4-fold; < 0.05). After combined treatment with forskolin and cholera toxin the increase in total cAMP concentrations was similar to that elicited by cholera toxin alone. Concentrations were 1.7-fold lower in 16-day-old embryos than in 13-day-old embryos (P < 0.05).
Total (Fredholm et ah, 1994) . A concentration of 1 mmol IBMX l"1 effectively prevented cyclic nucleotide hydrolysis.
In the dose-response study, 100 pmol forskolin l1 was the most effective concentration and this was used in subsequent experiments. This concentration of forskolin was effective in activating adenylyl cyclase in mouse and cattle oocytes (Schultz et ah, 1983; Bilodeau et ah, 1993) . In the present study, the increase in total cAMP concentrations in cattle embryos elicited by forskolin ranged from 5.5-fold at day 13 to 2.7-fold at day 16. This is lower than the 25-fold increase in zona-free cattle oocytes reported by Bilodeau et ah (1993) who used the same concentration of forskolin, but it is within the range reported by Manejwala et ah (1986) (Manejwala et ah, 1986; Bilodeau et ah, 1993) , but is consistent with mouse blastocysts in which cholera toxin is more effective than forskolin. However, in mouse blastocysts, cholera toxin induces only a 12-fold increase in cAMP over IBMX controls compared with an increase of 20-to 25-fold in the present study.
The increase in cGMP concentrations elicited by cholera toxin at 20 pg ml"1 was unexpected, since cholera toxin is a specific activator of adenylyl cyclase. Although there are no similar reports for embryos, Ledoux et ah (1997) reported increased cGMP concentrations in renal cells after treatment with cholera toxin (20 pg ml"1). They proposed that the effect was due to modulation of cGMP production by PKA through an intermediary protein.
The increase in intra-and extracellular cAMP concen¬ trations induced by combined treatment with forskolin and cholera toxin was similar to that elicited by cholera toxin alone, but greater than that elicited by forskolin alone.
This lack of synergism of forskolin and cholera toxin is in contrast to the study of Manejwala et ah (1986) (1996) reported a marked increase in embryo size and protein content during this time. Since cGMP inhibits proliferation in vascular smooth muscle cells (Sarkar et ah, 1997; Yu et ah, 1997) and osteoblastic cells (Hagiwara et ah, 1996) , it is possible that the decrease in cGMP concentrations in 15-to 16-day-old embryos is a signal for proliferation within the embryo. Nitric oxide, which acts by increasing cGMP concentrations, is produced by preimplantation mouse embryos and is required for their development (Gouge et ah, 1998) . However, high concentrations of nitric oxide inhibit both embryo development in vitro and implantation in vivo in mice (Barroso et ah, 1998 indicates that cGMP has an important role as an extracellular messenger in addition to its intracellular role.
The present study augments the data on the export of cAMP and cGMP by cattle embryos (Grealy et ah, 1997 (Cox and Leese, 1995) and in mouse (Chan et ah, 1997) , rat (Dehpour et ah, 1994) and guinea-pig (Haynes and Pennefather, 1993; Piper and Hollingsworth, 1996) uterine epithelia, although there are no reports of their presence in embryos. Adenosine, acting via increased cAMP concentrations, inhibits prolif¬ eration in smooth muscle cells (Jonzon et ah, 1985) . Decreased cAMP concentrations may therefore stimulate proliferation.
